As Hal Bar­ron steals the show, there’s no off po­si­tion on the John Maraganore switch; Dan­ny Bar-Zo­har makes an­oth­er leap for­ward at Mer­ck KGaA

→ The nee­dle on the Maraganore Me­ter is mov­ing again, as John Maraganore keeps col­lect­ing more post-Al­ny­lam roles. First, he and BeiGene co-founder Pe­ter Ho will be strate­gic ad­vi­sors for Hill­house-backed Chi­na start­up Over­land Phar­ma­ceu­ti­cals, found­ed by Hua Mu and Ed Zhang. (By the way, Zhang has been named per­ma­nent CEO of Over­land this week af­ter the one-time COO and CBO served as in­ter­im chief since May.) Next, Maraganore has been elect­ed to the board of di­rec­tors at pro­tein degra­da­tion biotech Kymera Ther­a­peu­tics — a board chaired by Bruce Booth that in­cludes Don Nichol­son and out­go­ing Blue­print Med­i­cines CEO Jeff Al­bers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER